Which clinical and experimental data link temporal lobe epilepsy with depression?

Area of Science:

• Neuroscience
• Psychiatry
• Epileptology

Background:

• The comorbidity of temporal lobe epilepsy (TLE) and depression is long-established.
• Recent advancements in neuroimaging and animal models reveal shared pathophysiological underpinnings.

Purpose of the Study:

• To review current experimental and clinical data on the common mechanisms linking TLE and depression.
• To explore the bidirectional relationship and potential therapeutic targets.

Main Methods:

• Review of in vivo and ex vivo studies, including Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and Magnetic Resonance Spectroscopy (MRS).
• Analysis of refined animal models and behavioral tests.
• Integration of clinical data on neuropsychiatric disorders.

Main Results:

• Evidence suggests altered serotonergic, noradrenergic, and glutamatergic systems leading to neuronal hyperexcitability in both TLE and depression.
• Decreased neurotransmitter levels and elevated glucocorticoids impact neurotrophic factors, potentially causing hippocampal atrophy and amygdala changes.
• PET studies indicate hypometabolism in temporal and frontal lobes; astrocytes play a significant role.

Conclusions:

• Shared mechanisms, including neuronal hyperexcitability and glial-neuronal interactions, link TLE and depression.
• These conditions likely have a bidirectional relationship, where one increases the risk for the other.
• Therapeutic strategies targeting glial-neuronal interactions may offer future treatment avenues.